Chengdi Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Pulmonary Tuberculosis

Patient Reported

Epidermal Growth Factor Receptor

Top Venues

Signal transduction and targeted therapy

Journal of medical Internet research

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chengdi Wang, Jun Shao, Yichu He, Jiaojiao Wu, Xingting Liu, Liuqing Yang, Ying Wei, Xiang Sean Zhou, Yiqiang Zhan, Feng Shi, Dinggang Shen, Wei-Min Li
Data-driven risk stratification and precision management of pulmonary nodules detected on chest computed tomography. Nature medicine (2024)
Peiyi Li, Chenyang Zhang, Shuanliang Gao, Yan-Bo Zhang, Xiaolong Liang, Chengdi Wang, Tao Zhu, Wei-Min Li
Association Between Daily Internet Use and Incidence of Chronic Diseases Among Older Adults: Prospective Cohort Study. Journal of medical Internet research 25 (2023)
Mengyuan Lyu, Jian Zhou, Yanbing Zhou, Weelic Chong, Wei Xu, Hongli Lai, Lu Niu, Yang Hai, Xiaojun Yao, Sheng Gong, Qinglan Wang, Yi Chen, Yili Wang, Liyu Chen, null Zengwanggema, Jiongjiong Zeng, Chengdi Wang, Binwu Ying
From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism. Signal transduction and targeted therapy 8 (1) (2023)
Mengyuan Lyu, Jian Zhou, Yanbing Zhou, Weelic Chong, Wei Xu, Hongli Lai, Lu Niu, Yang Hai, Xiaojun Yao, Sheng Gong, Qinglan Wang, Yi Chen, Yili Wang, Liyu Chen, null Zengwanggema, Jiongjiong Zeng, Chengdi Wang, Binwu Ying
From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism. Signal transduction and targeted therapy 8 (1) (2023)
Jingwei Li, Yun Zhou, Jiechao Ma, Qin Zhang, Jun Shao, Shufan Liang, Yizhou Yu, Wei-Min Li, Chengdi Wang
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Signal transduction and targeted therapy 8 (1) (2023)
Mengyuan Lyu, Jian Zhou, Yanbing Zhou, Weelic Chong, Wei Xu, Hongli Lai, Lu Niu, Yang Hai, Xiaojun Yao, Sheng Gong, Qinglan Wang, Yi Chen, Yili Wang, Liyu Chen, null Zengwanggema, Jiongjiong Zeng, Chengdi Wang, Binwu Ying
From tuberculosis bedside to bench: UBE2B splicing as a potential biomarker and its regulatory mechanism. Signal transduction and targeted therapy 8 (1) (2023)
Chengdi Wang, Qiuxiao Yu, Tingting Song, Zhoufeng Wang, Lujia Song, Ying Yang, Jun Shao, Jingwei Li, Yinyun Ni, Ningning Chao, Li Zhang, Wei-Min Li
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. Signal transduction and targeted therapy 7 (1) (2022)
Chengdi Wang, Jingwei Li, Qiran Zhang, Jiayang Wu, Yuxuan Xiao, Lujia Song, Hanlin Gong, Yalun Li
The landscape of immune checkpoint inhibitor therapy in advanced lung cancer. BMC cancer 21 (1) (2021)
Jun Shao, Jingwei Li, Lujia Song, Qiuyao He, Yuxuan Wu, Linhui Li, Dan Liu, Chengdi Wang, Wei-Min Li
The number of brain metastases predicts the survival of non-small cell lung cancer patients with EGFR mutation status. Cancer reports (Hoboken, N.J.) (2021)
Chengdi Wang, Yuxuan Wu, Jun Shao, Dan Liu, Wei-Min Li
Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer. BMC cancer 20 (1) (2020)
Chengdi Wang, Wenliang Qiao, Yuting Jiang, Min Zhu, Jun Shao, Pengwei Ren, Dan Liu, Wei-Min Li
Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer. Cancer medicine 8 (8) (2019)
Chengdi Wang, Wenliang Qiao, Yuting Jiang, Min Zhu, Jun Shao, Tao Wang, Dan Liu, Wei-Min Li
The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis. Journal of cellular physiology 235 (5) (2019)